Abstract:Background:Autologous stem cell transplantation (ASCT) still plays an role in treatment of acute lymphoblastic leukemia (ALL). A myeloablative conditioning therapy should be done before ASCT. Many trials comparing regimens with total body irradiation (TBI) and non‐TBI in allogeneic stem cell tansplantation have been reported. However, very limited analysis focused on patients with ALL undergoing ASCT.Aims:The present study was undertaken to analyse retrospectively the outcome following conditioning with TBI regimens versus non‐TBI regimens in ASCT in adolescents and young adults with Philadelphia chromosome‐negative ALL patient cohorts.Methods:We defined 14–29 years of age as AYAs. Seventy four AYAs of all 95 patients with ALL undergoing consecutive ASCT between January 2007 and December 2016 were included in the study at Lymphoma Center at Blood Disease Hospital of Chinese Academy of Medical Sciences. Patients were chose based on the following criteria: (1) CR1 before ASCT; (2) first ASCT; (3) peripheral blood stem cell; (4) Philadelphia chromosome‐negative; (5) no definite central nervous system disease. According to the conditioning regimens administered, patients were divided into the following two groups: TBI group (consisting of TBI and chemotherapy, n = 38) and non‐TBI group (consisting of only chemotherapy, n = 36). The details of TBI‐based conditioning were TBI plus melphalan ± etoposide(n = 21), TBI plus cyclophosphamide ± cytosine arabinoside or etoposide (n = 14), others (n = 3). The details of non‐TBI conditioning were busulfan plus melphalan (n = 6), busulfan plus cyclophosphamide and etoposide (n = 16), busulfan plus cyclophosphamide and cytosine arabinoside (n = 3), busulfan plus cyclophosphamide and idarubicin (n = 6), others (n = 5). All of patients were received with VDCP ± L induction regimen for 28 days, then patients were administered with four courses of intensive chemotherapy. All of patients received 8–10 intrathecal injections for preventing central nervous system disease. After ASCT, maintenance chemotherapy based on VP regimen was continued for 1–1.5 years.Results:The main features at the time of diagnosis and transplant characteristics (sex, age, number of leukocytes, phenotype, karyotype and molecular biology, interval from treatment to MRD negative, interval between CR1 to patients transplanted) are parallel between the two groups. The median follow‐up for the survivors was 56 months (range, 30 ‐ 130 months) for TBI group and 65 months (range, 27 ‐ 126 months) for non‐TBI group after ASCT, respectively (P = 0.563). The median neutrophil engraftment days were 11days (range, 8–19 days) and 12 days (range, 9–30 days) for TBI group and non‐TBI group (P = 0.432), respectively. The median days to platelet engraftment were 15days (range, 10–95 days) and 14.5 days (range, 9–90 days) (P = 0.656), respectively. Hepatic vein occlusion syndrome occurred in 1 patients administered by busulfan plus melphalan conditioning at the day of 32 from transplantation. Cataract occurred in TBI plus melphalan (n = 1) conditioning group and TBI plus melphalan and etoposide conditioning group (n = 1).Non TRM occurred. The 5‐year disease‐free survival (DFS) was 68.1 ± 7.6% in TBI cohort and 62.3 ± 8.4% in non‐TBI cohort (P = 0.906). The 5‐year overall survival (OS) was 67.5 ± 7.8% and 63.8 ± 8.6% (P = 0.694). The DFS and OS results were no differences between the two regimens in univariate analysis.Summary/Conclusion:These data indicate similar survival with non‐TBI conditioning, compared with TBI‐based conditioning, for ASCT in adolescents and young adults with Philadelphia chromosome‐negative ALL.image

Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia

Total Body Irradiation–Based Conditioning Regimen Improved the Survival of Adult Patients with T-Cell Lymphoblastic Lymphoma after Allogeneic Peripheral Blood Stem Cell Transplantation

Conditioning Regimen with or Without Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Ieukemia

Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study

PS964 COMPARISON OF CONDITIONING REGIMEN CONTAINING TOTAL BODY IRRADIATION OR NOT FOR AUTOLOGOUS TRANSPLANTATION IN ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph‐negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation

Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: an Open-Label, Multicenter, Phase III Trial

TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL

Comparable Outcomes After Busulfan- Or Treosulfan-Based Conditioning For Allo-Hsct In Children With All – Results Of Forum

Total Body Irradiation and Cyclophosphamide Plus Antithymocyte Globulin Regimen is Well Tolerated and Promotes Stable Engraftment As A Preparative Regimen Before T Cell-Replete Haploidentical Transplantation for Acute Leukemia

The Safety and Efficacy of a Novel Hypo-Fractionated Total Marrow and Lymphoid Irradiation Before Allogeneic Stem Cell Transplantation for Lymphoma and Acute Leukemia

Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols

TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia

TBI/Ratg-Based Conditioning for Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in 11 Cases of Chemotherapy-Resistant Advanced-Stage Peripheral T-Cell Lymphoma

Intravenous Busulfan-Cyclophosphamide As a Preparative Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia.

Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature

[Comparison of Total Body Irradiation-Cyclophosphamide Versus Busulphan-Cyclophosphamide As Conditioning Regimens for Myelogenous Leukemia: a Meta-Analysis].

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.